|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2018||2019||2020||2021||2022||2023E||2024E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
- Christoph Franz NEC (61)
- Severin Schwan CEO (55)
- Andre Hoffmann NVC (64)
- Alan Hippe CFO (55)
- Cristina Wilbur CHO (55)
- Pascale Schmidt CCO (49)
- Claudia Boeckstiegel GCN (58)
- William Anderson EXB (54)
- William Pao EXB (55)
- Aviv Regev EXB (51)
- James Sabry EXB (62)
- Barbara Schaedler EXB (60)
- Thomas Schinecker EXB (47)
- Per-Olof Attinger SEC (62)
- Annette Luther SEC (52)
- Julie Brown NID (60)
- Paul Bulcke NID (68)
- Hans Clevers NID (65)
- Joerg Duschmale NID (38)
- Patrick Frost NID (54)
- Anita Hauser NID (53)
- Richard Lifton NID (69)
- Bernard Poussot NID (70)
- Claudia Suessmuth Dyckerhoff NID (55)
Latest News for ROG
Upcoming Events for ROG
Roche Holding AG at Evercore ISI HealthCONx Conference
Roche Holding AG Digitalisation Day
Roche Holding AG at Berenberg Pharma CFO Series
Roche Holding AG at JPMorgan CEO Conference Call Series
Roche Holding AG at Exane BNPP DILS CEO Conference (Virtual)
Roche Holding AG ASH Virtual Event
Full Year 2023 Roche Holding AG Earnings Release
Roche Holding AG Annual Shareholders Meeting
Roche Holding AG Annual Shareholders Meeting
Q1 2024 Roche Holding AG Corporate Sales Release
Roche Holding AG Diagnostics Day
As of Today at 18:18 UTC, shares in Roche Holding AG are trading at CH₣238.70. This share price information is delayed by 15 minutes.
Shares in Roche Holding AG last closed at CH₣238.70 and the price had moved by -22.64% over the past 365 days. In terms of relative price strength the Roche Holding AG share price has underperformed the FTSE Global All Cap Index by -26.03% over the past year.
The overall consensus recommendation for Roche Holding AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The Roche Holding AG dividend yield is 3.98% based on the trailing twelve month period.
Last year, Roche Holding AG paid a total dividend of CH₣9.50, and it currently has a trailing dividend yield of 3.98%. We do not have any data on when Roche Holding AG is to next pay dividends.
We do not have data on when Roche Holding AG is to next pay dividends. The historic dividend yield on Roche Holding AG shares is currently 3.98%.
To buy shares in Roche Holding AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CH₣238.70, shares in Roche Holding AG had a market capitalisation of CH₣190.64bn.
Here are the trading details for Roche Holding AG:
- Country of listing: Switzerland
- Exchange: SWX
- Ticker Symbol: ROG
Based on an overall assessment of its quality, value and momentum Roche Holding AG is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Roche Holding AG is CH₣301.30. That is 26.23% above the last closing price of CH₣238.70.
Analysts covering Roche Holding AG currently have a consensus Earnings Per Share (EPS) forecast of CH₣18.75 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Roche Holding AG. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -17.53%.
As of the last closing price of CH₣238.70, shares in Roche Holding AG were trading -9.82% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Roche Holding AG PE ratio based on its reported earnings over the past 12 months is 11.93. The shares last closed at CH₣238.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Roche Holding AG's management team is headed by:
- Christoph Franz - NEC
- Severin Schwan - CEO
- Andre Hoffmann - NVC
- Alan Hippe - CFO
- Cristina Wilbur - CHO
- Pascale Schmidt - CCO
- Claudia Boeckstiegel - GCN
- William Anderson - EXB
- William Pao - EXB
- Aviv Regev - EXB
- James Sabry - EXB
- Barbara Schaedler - EXB
- Thomas Schinecker - EXB
- Per-Olof Attinger - SEC
- Annette Luther - SEC
- Julie Brown - NID
- Paul Bulcke - NID
- Hans Clevers - NID
- Joerg Duschmale - NID
- Patrick Frost - NID
- Anita Hauser - NID
- Richard Lifton - NID
- Bernard Poussot - NID
- Claudia Suessmuth Dyckerhoff - NID